Vesicoureteric reflux and reflux nephropathy

• Published in: Indian journal of pediatrics Vol. 70; no. 3; pp. 241 - 249
• Main Authors: Goonasekera, Chulananda D A, Abeysekera, Chandra K
• Format: Journal Article
• Language: English
• Published: India 01.03.2003
• Subjects: Antibiotic Prophylaxis; Child; Disease Progression; Female; Humans; Male; Renal Insufficiency - etiology; Urinary Tract Infections - complications; Urinary Tract Infections - prevention & control; Vesico-Ureteral Reflux - complications; Vesico-Ureteral Reflux - diagnosis; Vesico-Ureteral Reflux - physiopathology; Vesico-Ureteral Reflux - therapy
• DOI: 10.1007/BF02725592
• ISSN: 0019-5456

Reflux nephropathy i.e. renal scarring associated with vesico-ureteric reflux (VUR) and urinary tract infection (UTI) was originally considered an acquired disease. The renal scarring seems to get worse with recurrent urine infections especially in the young. Therefore, in the past much effort was undertaken to correct the VUR surgically and minimize the number of recurrent urinary tract infections by antibiotic prophylaxis with the hope of reducing if not arresting the onset of complications that follow i.e. hypertension and renal failure. However, it is now becoming clear that reflux nephropathy encompass at least two major categories of disease; "acquired" renal scarring secondary to UTI and VUR predominantly affecting females and "congenital" scarring with dysplastic features associated with prenatal VUR but with no infection and predominantly affecting boys. The latter is much less common but is disproportionately represented in the group of patients with reflux nephropathy that go on to develop renal failure. Unfortunately, the susceptibility to renal scarring, the onset of hypertension and progression to renal failure seems to be significantly influenced by genetic factors and hence measures undertaken to prevent recurrence of UTI may not change the ultimate outcome although it will certainly improve the comfort of the individual. Therefore, the extensive investigation and management routines adopted today in these children may not be cost-effective in preventing end stage renal disease in VUR. The progression to renal failure, however, can be delayed but not halted with adequate control of high blood pressure and hence the need for life long follow-up.